The zebrafish homologue of Parkinson's disease ATP13A2 is essential for embryonic survival

被引:17
作者
da Fonseca, Tomas Lopes [1 ,4 ]
Correia, Ana [1 ,2 ]
Hasselaar, Wiebren [3 ]
van der Linde, Herma C. [3 ]
Willemsen, Rob [3 ]
Outeiro, Tiago Fleming [1 ,2 ,4 ]
机构
[1] Inst Mol Med, Cell & Mol Neurosci Unit, Lisbon, Portugal
[2] Univ Lisbon, Inst Fisiol, Fac Med, P-1649028 Lisbon, Portugal
[3] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands
[4] Univ Med Gottingen, Dept Neurodegenerat & Restorat Res, Ctr Mol Physiol Brain, D-37073 Gottingen, Germany
关键词
ATP13A2; Zebrafish; Parkinson's disease; Development; Kufor-Rakeb syndrome; ALPHA-SYNUCLEIN; PYRAMIDAL DEGENERATION; DANIO-RERIO; EXPRESSION; MUTATIONS; DEMENTIA; ATPASES; MODELS; GENES;
D O I
10.1016/j.brainresbull.2012.09.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
ATP13A2 is a lysosome-specific transmembrane ATPase protein of unknown function. This protein was initially linked to Kufor-Rakeb syndrome where it is absent or mutated. More recently, point mutations in ATP13A2 were linked to familial cases of Parkinson's disease. Zebrafish is commonly used as a vertebrate model for the study of different neurodegenerative diseases and has homologues of several Parkinson's disease associated proteins. Here, we describe for the first time the zebrafish homologue of human ATP13A2, demonstrating the homology between the protein sequences, which supports a conserved biological role. Furthermore, the spatial pattern of protein expression was studied and the lethality of the knockdown of ATP13A2 suggests it plays a crucial role during embryonic development. Our findings bring new insight into the biology of ATP13A2 and open novel opportunities for its study using zebrafish as a model organism. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:118 / 126
页数:9
相关论文
共 50 条
  • [1] ATP13A2 Variability in Taiwanese Parkinson's Disease
    Chen, Chiung-Mei
    Lin, Chih-Hsin
    Juan, Hsueh-Fen
    Hu, Fen-Ju
    Hsiao, Ya-Chin
    Chang, Hsin-Yi
    Chao, Chih-Ying
    Chen, I-Cheng
    Lee, Li-Ching
    Wang, Tsu-Wei
    Chen, Ya-Tang
    Chen, Yi-Tsun
    Lee-Chen, Guey-Jen
    Wu, Yih-Ru
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2011, 156B (06) : 720 - 729
  • [2] ATP13A2 Variability in Parkinson Disease
    Vilarino-Guell, Carles
    Soto, Alexandra I.
    Lincoln, Sarah J.
    Ben Yahmed, Samia
    Kefi, Mounir
    Heckman, Michael G.
    Hulihan, Mary M.
    Chai, Hua
    Diehl, Nancy N.
    Amouri, Rim
    Rajput, Alex
    Mash, Deborah C.
    Dickson, Dennis W.
    Middleton, Lefkos T.
    Gibson, Rachel A.
    Hentati, Faycal
    Farrer, Matthew J.
    HUMAN MUTATION, 2009, 30 (03) : 406 - 410
  • [3] Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease
    Sato, Shigeto
    Li, Yuanzhe
    Hattori, Nobutaka
    JOURNAL OF NEURAL TRANSMISSION, 2017, 124 (11) : 1395 - 1400
  • [4] ATP13A2 Variants in Early-Onset Parkinson's Disease Patients and Controls
    Djarmati, Ana
    Hagenah, Johann
    Reetz, Kathrin
    Winkler, Susen
    Behrens, Maria Isabel
    Pawlack, Heike
    Lohmann, Katja
    Ramirez, Alfredo
    Tadic, Vera
    Brueggemann, Norbert
    Berg, Daniela
    Siebner, Hartwig R.
    Lang, Anthony E.
    Pramstaller, Peter P.
    Binkofski, Ferdinand
    Kostic, Vladimir S.
    Volkmann, Jens
    Gasser, Thomas
    Klein, Christine
    MOVEMENT DISORDERS, 2009, 24 (14) : 2104 - 2111
  • [5] ATP13A2 protects dopaminergic neurons in Parkinson's disease: from biology to pathology
    Dang, Tao
    Cao, Wen-Jing
    Zhao, Rong
    Lu, Ming
    Hu, Gang
    Qiao, Chen
    JOURNAL OF BIOMEDICAL RESEARCH, 2022, 36 (02): : 98 - 108
  • [6] The Roles of ATP13A2 Gene Mutations Leading to Abnormal Aggregation of a-Synuclein in Parkinson's Disease
    Zhang, Fan
    Wu, Zhiwei
    Long, Fei
    Tan, Jieqiong
    Gong, Ni
    Li, Xiaorong
    Lin, Changwei
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [7] Lysosomal defects in ATP13A2 and GBA associated familial Parkinson’s disease
    Shigeto Sato
    Yuanzhe Li
    Nobutaka Hattori
    Journal of Neural Transmission, 2017, 124 : 1395 - 1400
  • [8] The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms
    Park, Jin-Sung
    Blair, Nicholas F.
    Sue, Carolyn M.
    MOVEMENT DISORDERS, 2015, 30 (06) : 770 - 779
  • [9] A lipid switch unlocks Parkinson's disease-associated ATP13A2
    Holemans, Tine
    Sorensen, Danny Mollerup
    van Veen, Sarah
    Martin, Shaun
    Hermans, Diane
    Kemmer, Gerdi Christine
    Van den Haute, Chris
    Baekelandt, Veerle
    Pomorski, Thomas Gunther
    Agostinis, Patrizia
    Wuytack, Frank
    Palmgren, Michael
    Eggermont, Jan
    Vangheluwe, Peter
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (29) : 9040 - 9045
  • [10] Genetic Association Study of the P-Type ATPase ATP13A2 in Late-Onset Parkinson's Disease
    Rakovic, Aleksandar
    Stiller, Barbara
    Djarmati, Ana
    Flaquer, Antonia
    Freudenberg, Jan
    Toliat, Mohammad-Reza
    Linnebank, Michael
    Kostic, Vladimir
    Lohmann, Katja
    Paus, Sebastian
    Nuernberg, Peter
    Kubisch, Christian
    Klein, Christine
    Wuellner, Ullrich
    Ramirez, Alfredo
    MOVEMENT DISORDERS, 2009, 24 (03) : 429 - 433